24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Direct Offering
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:54
Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”
11:27
Innovation or exhaustion? The human cost of tech’s AI reset
10:21
When the user is no longer human: The bot social network is the internet’s watershed moment
09:32
“The next AI revolution will be powered by energy, cooling, and physical infrastructure”
More stories
Buzz
Most popular
Daily
Weekly
1
Why Apple paid billions for a company with no revenue
2
Valued at $800 million after less than two years, Vega eyes the path blazed by Wiz
3
Google-Wiz deal expected to be cleared by EU following meeting with regulators, report says
4
Israeli startups raise over $1 billion in January, marking best opening month since 2022
5
From secret satellites to civilian services: Israel’s space industry reinvents itself
More news
Direct Offering
4 stories about Direct Offering
Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering
10.07.18
|
CTech
Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
Biotech Company Compugen Down on Nasdaq Following $21 Million Direct Offering
17.06.18
|
Dror Reich
The Israel-based cancer immunotherapy company intends to use the proceedings for product development
OrbiMed Invests $16 Million in Derma Company Foamix
17.04.18
|
Lilach Baumer
Foamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne
Liver Treatment Company Galmed is Raising $6 Million in Direct Offering
04.04.18
|
Lilach Baumer
The company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014